1. Home
  2. FOLD vs KAR Comparison

FOLD vs KAR Comparison

Compare FOLD & KAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOLD
  • KAR
  • Stock Information
  • Founded
  • FOLD 2002
  • KAR 2006
  • Country
  • FOLD United States
  • KAR United States
  • Employees
  • FOLD N/A
  • KAR N/A
  • Industry
  • FOLD Biotechnology: Pharmaceutical Preparations
  • KAR Retail-Auto Dealers and Gas Stations
  • Sector
  • FOLD Health Care
  • KAR Consumer Discretionary
  • Exchange
  • FOLD Nasdaq
  • KAR Nasdaq
  • Market Cap
  • FOLD 2.9B
  • KAR 2.4B
  • IPO Year
  • FOLD 2007
  • KAR 2009
  • Fundamental
  • Price
  • FOLD $5.64
  • KAR $22.28
  • Analyst Decision
  • FOLD Buy
  • KAR Buy
  • Analyst Count
  • FOLD 10
  • KAR 4
  • Target Price
  • FOLD $16.22
  • KAR $24.00
  • AVG Volume (30 Days)
  • FOLD 5.3M
  • KAR 724.3K
  • Earning Date
  • FOLD 08-07-2025
  • KAR 08-06-2025
  • Dividend Yield
  • FOLD N/A
  • KAR N/A
  • EPS Growth
  • FOLD N/A
  • KAR N/A
  • EPS
  • FOLD N/A
  • KAR 0.58
  • Revenue
  • FOLD $543,141,000.00
  • KAR $1,818,700,000.00
  • Revenue This Year
  • FOLD $19.84
  • KAR $1.93
  • Revenue Next Year
  • FOLD $23.18
  • KAR $6.25
  • P/E Ratio
  • FOLD N/A
  • KAR $38.43
  • Revenue Growth
  • FOLD 28.25
  • KAR 6.67
  • 52 Week Low
  • FOLD $5.62
  • KAR $15.44
  • 52 Week High
  • FOLD $12.65
  • KAR $24.42
  • Technical
  • Relative Strength Index (RSI)
  • FOLD 33.65
  • KAR 47.02
  • Support Level
  • FOLD $6.00
  • KAR $23.38
  • Resistance Level
  • FOLD $6.22
  • KAR $24.42
  • Average True Range (ATR)
  • FOLD 0.19
  • KAR 0.50
  • MACD
  • FOLD -0.01
  • KAR -0.28
  • Stochastic Oscillator
  • FOLD 2.70
  • KAR 7.94

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

About KAR OPENLANE Inc.

Openlane Inc provides a digital marketplace for used vehicles, connecting sellers and buyers in North America and Europe for fast and transparent transactions. Its services include financing, repossessions, repairs, transportation, warranty, and inventory management. The company operates used-vehicle auctions and has two main segments: Marketplace and Finance, with majority revenue coming from the Marketplace segment, which to used vehicle remarketing, including marketplace services, remarketing, or make ready services and all are interrelated, synergistic elements along the auto remarketing chain. The Finance segment, through AFC engaged in business of providing short-term, inventory-secured financing to independent vehicle dealers.

Share on Social Networks: